Form 4 for AVIR Atea Pharmaceuticals, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0000950170-24-070965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2024-06-07 | 2024-06-05 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | S - Sale | $4.00 | -1,006 | 5.92M | -0.0% | -$4,024 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | S | D | 1,006 | $4.00 | 5,923,994 | I Held by JPM Partners LLC | — | — |